Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Regular ✕ICICI Prudential Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseInvescoICICI Pru
NAV₹10.7400₹25.6900
NAV date20 Nov 202619 Nov 2026
History2 months5.8 years
Expense ratio3.8%1.8%
StarsNot rated★★★★★
Growth Score—77.50

Returns

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
1 month+19.60%+10.02%
3 months—+3.63%
6 months—+6.82%
YTD—−0.16%
1 year—−0.19%
3 years (CAGR)—+15.23%
5 years (CAGR)—+14.54%
10 years (CAGR)——
Since launch+7.29%+17.53%

Risk

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
Volatility—15.0%
Downside volatility—9.8%
Sharpe—0.58
Sortino—0.89
Calmar—1.03
Return / risk—1.02
Deepest fall−11.50%−14.74%
Days to recover14118
Below its high+0.00%−1.50%

Against benchmark

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
Alpha—+3.13%
Beta—0.90
R²—92.7%
Up capture—99.9%
Down capture—82.7%
Tracking error—4.4%
Information ratio—0.59
Treynor—0.08

Consistency

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
Best 1-year—+56.26%
Middle 1-year—+12.61%
Worst 1-year—−10.53%
1-year periods with a loss—5.0%
Middle 3-year—+22.02%
Positive months—61.1%
Best day+3.52%+4.47%
Worst day−2.74%−5.44%
Worst 5% day−1.46%−1.25%
Positive days46.8%54.8%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundICICI Prudential Business Cycle Fund
5-year XIRR—+14.12%
5-year value—₹8,60,368
3-year XIRR—+8.23%
1-year XIRR—+7.14%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth